Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

MS

Navigating Morgan Stanley – A Brief Guide for Investors

A strong performer from today's morning trading session is Morgan Stanley, whose shares rose 1.1% to $153.97 per share. For those of you thinking about investing in the stock, here is a brief value analysis of the stock using the company's basic fundamental ratios.

Morgan Stanley's Valuation Is in Line With Its Sector Averages:

Morgan Stanley, a financial holding company, provides various financial products and services to governments, financial institutions, and individuals in the Americas, Asia, Europe, Middle East, and Africa. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 15.92 and an average price to book (P/B) ratio of 1.78. In contrast, Morgan Stanley has a trailing 12 month P/E ratio of 17.4 and a P/B ratio of 2.5.

Morgan Stanley has moved 56.9% over the last year compared to 17.3% for the S&P 500 — a difference of 39.6%. Morgan Stanley has a 52 week high of $154.05 and a 52 week low of $94.09.

Increasing Revenues but Narrowing Margins:

2019 2020 2021 2022 2023 2024
Revenue (M) $17,098 $10,162 $9,411 $21,595 $45,849 $54,135
Interest Income (M) $4,694 $6,313 $8,045 $9,327 $8,230 $8,611
Net Income (M) $9,042 $10,996 $15,034 $11,029 $9,087 $13,390
Depreciation & Amort. (M) $2,643 $3,769 $4,216 $3,998 $4,256 $5,161
Diluted Shares (M) 1,640 1,624 1,814 1,713 1,646 1,611
Earnings Per Share $5.19 $6.46 $8.03 $6.15 $5.18 $7.95
EPS Growth n/a 24.47% 24.3% -23.41% -15.77% 53.47%
Avg. Price $39.37 $45.19 $85.09 $85.06 $93.25 $152.22
P/E Ratio 7.48 6.9 10.43 13.65 17.8 18.93
Free Cash Flow (M) $38,947 -$26,675 $31,663 -$9,475 -$36,948 -$2,100
CAPEX (M) $1,826 $1,444 $2,308 $3,078 $3,412 $3,462
EV / EBITDA 18.15 9.9 10.63 14.22 20.42 18.8
Total Debt (M) $190,060 $213,388 $227,363 $233,867 $260,544 $284,307
Net Debt / EBITDA 13.32 5.92 4.17 5.85 10.66 7.86
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS